QuestionsSo many questions come to mind:
What will Shiseido do now that they have the green light to market the hair restoration tecnology in Asia ?
* Did their most recent Trial prove out the technology ?
* Is it enough to take it to market in Asia ?
* Are they interested in acquiring the global rights from Replicel ?
I would assume with this latest setback that Jamie and Andrew would push for a deal with Shiseido.
What is happening with Mainpointe Pharmaceutical ?
* Are the funding the final development of the device ?
* Are they seeking a North American manufacturer ?
* How far away are they from seeking FDA Approval ?
What is happening with Yofoto ?
* Is the same thing happening with Yofoto that happened with Shiseido ?
* Why do we hear nothing from Replicel regarding their relationship with Yofoto ?
Jamie & Andrew
* Did they have a plan B if the Arbitration went against Replicel ?
* Do they have an appetite to continue funding the company ?
It is time for a detailed update of where Replicel goes from here and we need it now !